SARS-CoV-2 Causes Brain Damage: Therapeutic Intervention with AZD8797
dc.authorid | onen, engin alp/0000-0003-1661-5803 | |
dc.authorid | KÖROĞLU, AYÇA KARAGÖZ/0000-0002-2532-8091 | |
dc.authorid | Sevic Yilmaz, Erva/0000-0002-0178-0112 | |
dc.authorwosid | Kervancioglu Demirci, Elif/GQP-2823-2022 | |
dc.authorwosid | onen, engin alp/AAX-3151-2021 | |
dc.authorwosid | KÖROĞLU, AYÇA KARAGÖZ/AAL-9416-2020 | |
dc.contributor.author | Demirci, Elif Kervancioglu | |
dc.contributor.author | Onen, Engin Alp | |
dc.contributor.author | Yilmaz, Erva Sevic | |
dc.contributor.author | Koroglu, Ayca Karagoz | |
dc.contributor.author | Akakin, Dilek | |
dc.date.accessioned | 2024-05-19T14:40:32Z | |
dc.date.available | 2024-05-19T14:40:32Z | |
dc.date.issued | 2023 | |
dc.department | İstinye Üniversitesi | en_US |
dc.description.abstract | Elevated CX3CL1 is associated with severe COVID-19 and neurologic symptoms. We aimed to investigate the potential protective effects of selective CX3CR1 antagonist AZD8797 on SARS-CoV-2-induced neuronal damage, and to identify the underlying mechanisms. K18-hACE2 transgenic mice (n = 37) were randomly divided into control groups and SARS-CoV-2 groups, with and without intraperitoneal administration of vehicle or AZD8797 (2.5 mg/mL/day), following exposure to either a single dose of SARS-CoV-2 inhalation or no exposure. Object recognition and hole board tests were performed to assess memory function. Postinfection 8 days, brain tissues were analyzed for histopathological changes, viral, glial, apoptotic, and other immunohistochemical markers, along with measuring malondialdehyde, glutathione, and myeloperoxidase activities. Serum samples were analyzed for proinflammatory cytokines. The SARS-CoV-2 group showed significant weight loss, neuronal damage, oxidative stress, and impaired object recognition memory, while AZD8797 treatment mitigated some of these effects, especially in weight, apoptosis, glutathione, and MCP-1. Histopathological analyses supported the protective effects of AZD8797 against SARS-CoV-2-induced damage. The CX3CL1-CX3CR1 signaling pathway could offer a promising target for reducing SARS-CoV-2's neurological impact, but additional research is needed to confirm these findings in combination with other therapies and assess the clinical significance. | en_US |
dc.description.sponsorship | We thank Prof. Gulnaz Nural Bekiroglu of the Department of Biostatistics at Marmara School of Medicine for her statistical guidance, Dr. Turkan Koyuncuoglu of the Department of Physiology at Biruni University for her theoretical suggestions in behavioral t | en_US |
dc.description.sponsorship | We thank Prof. Gulnaz Nural Bekiroglu of the Department of Biostatistics at Marmara School of Medicine for her statistical guidance, Dr. Turkan Koyuncuoglu of the Department of Physiology at Biruni University for her theoretical suggestions in behavioral tests, and DVM Ersun Bilecen for his assistance with animal care and behavioral tests. | en_US |
dc.identifier.doi | 10.1093/micmic/ozad129 | |
dc.identifier.endpage | 2173 | en_US |
dc.identifier.issn | 1431-9276 | |
dc.identifier.issn | 1435-8115 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 37967299 | en_US |
dc.identifier.scopus | 2-s2.0-85181177264 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 2161 | en_US |
dc.identifier.uri | https://doi.org10.1093/micmic/ozad129 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/4976 | |
dc.identifier.volume | 29 | en_US |
dc.identifier.wos | WOS:001101855800001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Oxford Univ Press | en_US |
dc.relation.ispartof | Microscopy and Microanalysis | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | 20240519_ka | en_US |
dc.subject | Covid-19 | en_US |
dc.subject | Cx3cl1 | en_US |
dc.subject | Histology | en_US |
dc.subject | Oxidative Stress | en_US |
dc.subject | Transgenic Mice | en_US |
dc.title | SARS-CoV-2 Causes Brain Damage: Therapeutic Intervention with AZD8797 | en_US |
dc.type | Article | en_US |